US Submarine Power Cable Market

ID: MRFR/EnP/16701-HCR
100 Pages
Garvit Vyas
Last Updated: June 17, 2026
US Submarine Power Cable Market Research Report: By Type (AC, DC), By Core Type (Single Core, Multi-Core), By Insulation Type (Cross-Linked Polyethylene (XLPE), Ethylene Propylene Rubber (EPR)), By Voltage (Up to 66 KV, 66 KV-220 KV, Above 220 KV), By Conductor Material (Copper, Aluminum) and By End-Use (Offshore Wind Power Generation, Offshore Oil & Gas, Island Connection, Wave & Tidal Power Generation) - Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Pharmaceutical, BY Type (USD Million) | |
      1. 4.1.1 Single Core | |
      2. 4.1.2 Multi-Core |
    2. 4.2 Pharmaceutical, BY Insulation Type (USD Million) | |
      1. 4.2.1 Cross-linked polyethylene (XLPE) | |
      2. 4.2.2 Ethylene propylene rubber (EPR) |
    3. 4.3 Pharmaceutical, BY Conductor Material (USD Million) | |
      1. 4.3.1 Copper | |
      2. 4.3.2 Aluminum |
    4. 4.4 Pharmaceutical, BY End Use (USD Million) | |
      1. 4.4.1 Offshore Wind Power Generation | |
      2. 4.4.2 Offshore Oil & Gas | |
      3. 4.4.3 Island Connection | |
      4. 4.4.4 Wave & Tidal Power Generation |
    5. 4.5 Pharmaceutical, BY Voltage (USD Million) | |
      1. 4.5.1 Up to 66 KV | |
      2. 4.5.2 66 KV-220 KV | |
      3. 4.5.3 Above 220 KV 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Nexans (FR) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Prysmian Group (IT) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 General Cable (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Subsea 7 (GB) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Siemens (DE) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 ABB (CH) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 JDR Cable Systems (GB) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 LS Cable & System (KR) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Telefónica (ES) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 US MARKET ANALYSIS BY TYPE |
    6. 6.3 US MARKET ANALYSIS BY INSULATION TYPE |
    7. 6.4 US MARKET ANALYSIS BY CONDUCTOR MATERIAL |
    8. 6.5 US MARKET ANALYSIS BY END USE |
    9. 6.6 US MARKET ANALYSIS BY VOLTAGE |
    10. 6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL |
    11. 6.8 RESEARCH PROCESS OF MRFR |
    12. 6.9 DRO ANALYSIS OF PHARMACEUTICAL |
    13. 6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL |
    14. 6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL |
    15. 6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL |
    16. 6.13 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE) |
    17. 6.14 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million) |
    18. 6.15 PHARMACEUTICAL, BY INSULATION TYPE, 2024 (% SHARE) |
    19. 6.16 PHARMACEUTICAL, BY INSULATION TYPE, 2024 TO 2035 (USD Million) |
    20. 6.17 PHARMACEUTICAL, BY CONDUCTOR MATERIAL, 2024 (% SHARE) |
    21. 6.18 PHARMACEUTICAL, BY CONDUCTOR MATERIAL, 2024 TO 2035 (USD Million) |
    22. 6.19 PHARMACEUTICAL, BY END USE, 2024 (% SHARE) |
    23. 6.20 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million) |
    24. 6.21 PHARMACEUTICAL, BY VOLTAGE, 2024 (% SHARE) |
    25. 6.22 PHARMACEUTICAL, BY VOLTAGE, 2024 TO 2035 (USD Million) |
    26. 6.23 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    27. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    28. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY INSULATION TYPE, 2025-2035 (USD Million) | |
      3. 7.2.3 BY CONDUCTOR MATERIAL, 2025-2035 (USD Million) | |
      4. 7.2.4 BY END USE, 2025-2035 (USD Million) | |
      5. 7.2.5 BY VOLTAGE, 2025-2035 (USD Million) |
    29. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    30. 7.4 ACQUISITION/PARTNERSHIP | |

US Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Million, 2025-2035)

  • Single Core
  • Multi-Core

Pharmaceutical By Insulation Type (USD Million, 2025-2035)

  • Cross-linked polyethylene (XLPE)
  • Ethylene propylene rubber (EPR)

Pharmaceutical By Conductor Material (USD Million, 2025-2035)

  • Copper
  • Aluminum

Pharmaceutical By End Use (USD Million, 2025-2035)

  • Offshore Wind Power Generation
  • Offshore Oil & Gas
  • Island Connection
  • Wave & Tidal Power Generation

Pharmaceutical By Voltage (USD Million, 2025-2035)

  • Up to 66 KV
  • 66 KV-220 KV
  • Above 220 KV